Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/24035
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKolibianakis, E. M.en
dc.contributor.authorZikopoulos, K.en
dc.contributor.authorSmitz, J.en
dc.contributor.authorCamus, M.en
dc.contributor.authorTournaye, H.en
dc.contributor.authorVan Steirteghem, A. C.en
dc.contributor.authorDevroey, P.en
dc.date.accessioned2015-11-24T19:37:28Z-
dc.date.available2015-11-24T19:37:28Z-
dc.identifier.issn0015-0282-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/24035-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectDrug Administration Scheduleen
dc.subjectFeasibility Studiesen
dc.subjectFemaleen
dc.subject*Fertilization in Vitroen
dc.subjectGonadotropin-Releasing Hormone/*administration & dosage/*analogs &en
dc.subjectderivatives/*antagonists & inhibitorsen
dc.subjectHormone Antagonists/*administration & dosageen
dc.subjectHumansen
dc.subject*Ovulation Inductionen
dc.subjectPregnancyen
dc.subjectPregnancy Rateen
dc.titleAdministration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilizationen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1016/j.fertnstert.2003.12.027-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/15237018-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0015028204006090/1-s2.0-S0015028204006090-main.pdf?_tid=51845fc227be9d4f12cd1207b63cd583&acdnat=1333460336_cbb32567b8fbbf2ca1de425cc7da4def-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2004-
heal.abstractAfter administration of GnRH antagonist from day 1 of stimulation for IVF, 12.1 cumulus oocyte complexes were retrieved (95% confidence interval [CI], 10.6-13.6), 1.9 embryos were transferred (95% CI, 1.7-2.0), and 2.4 embryos were cryopreserved (95% CI, 1.7-3.1). Stimulation for 8.8 days (95% CI, 8.4-9.2) with recombinant FSH resulted in an ongoing implantation rate of 26.5% (95% CI, 17.1-35.9) and an ongoing pregnancy rate of 39.7% per started cycle (95% CI, 30.1-50.8) and of 42.4% per ET (95% CI, 32.3-53.1).en
heal.journalNameFertil Sterilen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Kolibianakis-2004-Administration of go.pdf119.88 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons